HCA Healthcare, Inc. $HCA Shares Acquired by Swiss National Bank

Swiss National Bank increased its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 4.4% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 468,760 shares of the company’s stock after purchasing an additional 19,920 shares during the period. Swiss National Bank’s holdings in HCA Healthcare were worth $221,836,000 at the end of the most recent quarter.

A number of other hedge funds have also made changes to their positions in HCA. Sumitomo Life Insurance Co. raised its position in shares of HCA Healthcare by 1.0% during the 4th quarter. Sumitomo Life Insurance Co. now owns 2,026 shares of the company’s stock worth $946,000 after acquiring an additional 20 shares in the last quarter. MJP Associates Inc. ADV increased its stake in HCA Healthcare by 2.9% in the fourth quarter. MJP Associates Inc. ADV now owns 749 shares of the company’s stock valued at $350,000 after purchasing an additional 21 shares during the last quarter. Cary Street Partners Investment Advisory LLC lifted its position in shares of HCA Healthcare by 7.5% during the 4th quarter. Cary Street Partners Investment Advisory LLC now owns 300 shares of the company’s stock worth $140,000 after buying an additional 21 shares during the last quarter. Anchyra Partners LLC grew its position in shares of HCA Healthcare by 3.7% in the 1st quarter. Anchyra Partners LLC now owns 587 shares of the company’s stock valued at $278,000 after buying an additional 21 shares during the last quarter. Finally, Plato Investment Management Ltd lifted its position in HCA Healthcare by 0.6% in the fourth quarter. Plato Investment Management Ltd now owns 3,908 shares of the company’s stock valued at $1,833,000 after acquiring an additional 22 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on HCA shares. Raymond James Financial set a $528.00 target price on HCA Healthcare in a research report on Tuesday, July 7th. Wells Fargo & Company cut their price target on HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating on the stock in a research report on Monday, July 13th. Oppenheimer decreased their price objective on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a report on Monday, April 27th. Cantor Fitzgerald reduced their price target on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a research report on Tuesday, July 7th. Finally, TD Cowen dropped their price objective on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Fourteen equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $486.14.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $371.60 on Monday. The stock has a market capitalization of $82.44 billion, a PE ratio of 12.78, a price-to-earnings-growth ratio of 1.23 and a beta of 1.12. HCA Healthcare, Inc. has a 12 month low of $330.00 and a 12 month high of $556.52. The business has a 50 day simple moving average of $392.25 and a 200-day simple moving average of $456.93.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The firm had revenue of $19.11 billion during the quarter, compared to analyst estimates of $19.09 billion. During the same quarter last year, the business posted $6.45 EPS. The firm’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 29.73 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th were issued a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is currently 10.73%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.